Hidradenitis suppurativa (HS) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051119

This document outlines details of PBS-subsidised biological medicines for patients with moderate to severe hidradenitis suppurativa (HS).

HS and listing dates

Moderate to severe HS is a chronic skin condition featuring lumps in places such as the armpits or groin.

Listing dates:

A break in treatment cycles is measured:

from the date of last approval for PBS-subsidised biological medicine treatment in the most recent cycle
to the date of the first application for initial treatment with a biological medicine under the new treatment cycle

There is no limit to the number of treatment cycles.

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs, and choose the option relevant to the condition treated.

The Resources page contains: